Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
MiNK Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type | Security Class Title |
Fee Calculation Rule |
Amount Registered (1) |
Proposed Maximum Offering Price Per Unit |
Maximum Aggregate Offering Price |
Fee Rate |
Amount of Registration Fee | |||||||
| Equity | Common stock, $0.00001 par value per share |
Rules 457(c) |
4,640,000 | $0.798 (2) | $3,702,720.00 | 0.00014760 | $546.52 | |||||||
| Total Offering Amounts | $3,702,720.00 | $546.52 | ||||||||||||
| Total Fee Offsets (3) | — | |||||||||||||
| Net Fee Due | $546.52 | |||||||||||||
| (1) | The Registrant is hereby registering for resale from time to time by certain stockholders up to 4,640,000 shares of its common stock that were initially issued pursuant to the Stock Purchase Agreement dated as of May 14, 2024, by and between the Registrant and GKCC, LLC. Pursuant to Rule 416 under the Securities Act, this Registration Statement also covers such additional securities that may be issued as a result of stock splits, stock dividends or similar transactions. |
| (2) | Estimated solely for the purpose of calculating the registration fee in accordance with Rules 457(c) based on the average of the high and low prices of the registrant’s Common Stock as reported on the Nasdaq Capital Market on August 9, 2024 to be $0.8110 and $0.7850, respectively. |
| (3) | The Registrant does not have any fee off-sets. |